International Journal of Biological Macromolecules特刊的三年多审稿的反思
2017年1月3日投稿international journal of biological macromolecules ijbiomac-d-17-00001r2历经两次修改,在华人编辑的帮助下终于给了拒稿的通知:ms. ref. no.: ijbiomac-d-17-00001r2
title: retrogradation of sweet potato amylose and amylopectin with narrow molecular weight distribution
international journal of biological macromolecules
dear dr.
reviewers' comments on your work have now been received. you will see that they are advising against publication of your work. therefore i must reject it.
for your guidance, i append the reviewers' comments below.
thank you for giving us the opportunity to consider your work.
special issue guest editor: unfortunately, after two times revision there are still some problem leading the paper to major revision. hence, this paper is not enough for publishing yet.
thanks for your patience and understanding.
稿件转给特刊没有经过作者同意,特刊文章周期真的太长了,这篇文章写的什么我都差不多忘记了,期间催稿无数次,伊朗的一个责任编辑根本不搭理,好像已经换掉了,我们做科研的能等得起多少个3年呀。前车之鉴,供大家参考借鉴。
[ last edited by lianxijun2007 on 2020-3-21 at 22:29 ]
[ Last edited by lianxijun2007 on 2020-3-23 at 14:23 ]
返回小木虫查看更多
京公网安备 11010802022153号
三年不撤稿,估计只有你了,我3月没反应就要撤了!
请问楼主,这是哪天收到的邮件呀?我也是这个编辑处理的
祝福
换个期刊投吧,我去年投这个一个大修,一个小休,一个可能是据稿吧,编辑给拒了,后来中了Food & Function
不是我不撤,是不让我撤,系统没有撤稿操作,我给编辑说撤稿,人家不理,我给主编发信,主编催一次,他回一次,就是不拒不撤。
2020-03-20 16:57
谢谢了,已安排课题组老师改中文投稿了,自从疫情以来,我对SCI的认知已发生了改变,相信国家管理层面也会出台相关措施,使大家不再拼SCI影响因子和分区,同行评议将成为衡量科研水平的标准
,
为什么不换个外文期刊,何必又翻译成中文投!